Jade Biosciences, Inc. (JBIO)
16.57
+0.17
(+1.04%)
USD |
NASDAQ |
Nov 11, 16:00
16.57
0.00 (0.00%)
After-Hours: 17:43
Jade Biosciences EPS Diluted (Quarterly) : -0.7569 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7569 |
| March 31, 2026 | -0.5734 |
| December 31, 2025 | -0.6475 |
| September 30, 2025 | -0.636 |
| June 30, 2025 | -1.130 |
| March 31, 2025 | -423.36 |
| December 31, 2024 | -6.557 |
| September 30, 2024 | -5.158 |
| June 30, 2024 | -30.15 |
| March 31, 2024 | -29.20 |
| December 31, 2023 | -25.80 |
| September 30, 2023 | -24.77 |
| June 30, 2023 | -26.46 |
| Date | Value |
|---|---|
| March 31, 2023 | -23.34 |
| December 31, 2022 | -21.36 |
| September 30, 2022 | -19.45 |
| June 30, 2022 | -17.19 |
| March 31, 2022 | -15.64 |
| December 31, 2021 | -11.79 |
| September 30, 2021 | -8.867 |
| June 30, 2021 | -8.293 |
| March 31, 2021 | -4.006 |
| December 31, 2020 | -5.256 |
| September 30, 2020 | -3.527 |
| June 30, 2020 | -3.157 |
| March 31, 2020 | -2.059 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | -0.0232 |
| Savara, Inc. | -0.1691 |
| Vericel Corp. | 0.2674 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -55.76M |
| Total Expenses (Quarterly) | 55.76M |
| Enterprise Value | 581.74M |
| Earnings Yield | -15.77% |
| Normalized Earnings Yield | -15.77 |